Intellectual Property India Publishes Patent Application for Muscle Selective Hybrid Regulatory Combinations And Methods Of Use Thereof For The Treatment Of Myotonic Dystrophy Type 1

MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617076192 A) filed by Astellas Gene Therapies, Inc. on June 19, 2026, for Muscle Selective Hybrid Regulatory Combinations And Methods Of Use Thereof For The Treatment Of Myotonic Dystrophy Type 1.

Inventors include Nachtrab, Gregory Thomas; and Batra, Ranjan.

The application for the patent was published on September 18, 2026, under issue no. 38/2026.

Abstract: Disclosed are muscle-selective promoter combinations and RNA-targeting gene therapy compositions and methods comprising the same for treating DM1.

Disclaimer: Curated by HT Syndication.